Resources

The Zambia National Malaria Indicator Survey (MIS) 2018 is a nationally representative household survey designed to assess the coverage of key malaria interventions and the malaria and anemia prevalence of children under five years of age. The 2018 MIS is the sixth such malaria-focused household survey conducted in Zambia. It was conducted through the National Malaria Elimination Centre in April and May 2018 with the support of its partners, including PATH.

The Zambia National Malaria Indicator Survey (MIS) 2018 is a nationally representative household survey designed to assess the coverage of key malaria interventions and the malaria and anemia prevalence of children under five years of age. The 2018 MIS is the sixth such malaria-focused household survey conducted in Zambia. It was conducted through the National Malaria Elimination Centre in April and May 2018 with the support of its partners.

As decisions are being made about the future of partnerships under Horizon Europe, PATH and other Product Development Partnership (PDP) organizations call on the EU to once again include an ambitious partnership exclusively dedicated to funding research for the prevention and treatment of poverty-related and neglected diseases. In this position paper, PATH and partners specifically encourage enhanced partnership opportunities to bolster collaboration and leverage funding from partners, including PDPs and the private and philanthropic sectors, a more flexible portfolio approach to funding, and an ambitious doubling of the program to 1.36 billion Euros from the European Commission.

This installment of the PATH Malaria Learning Series highlights the PATH Market Dynamics program’s contribution to PATH’s work in the fight against malaria, providing an overview of our market access approach and highlighting three case studies. These case studies share PATH's experiences in ensuring access and availability of tools for malaria burden reduction and elimination such as G6PD testing, chloroquine, and artemisinin.The goal of the Malaria Learning Series is to provide concise briefings on the latest evidence in malaria science and learnings from across the PATH portfolio.

This immunization brief, written in French for a DRC audience in Tanganika province, discusses the ambitious "Mashako Plan" to increase routine immunization coverage in DRC by 15 percent in 18 months. The brief recommends that the provincial government emphasize routine immunization, deliver on the commitments of a recent memorandum of understanding with the Bill & Melinda Gates Foundation, and disburse immunization funding in order to bring the promise of immunization to all families in Tanganika.